About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Skeletal Metastasis Registry | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNCT05058014

Skeletal Metastasis Registry

This is a prospective, observational study designed to contribute data from patients with symptomatic metastatic bone disease treated at Sibley Memorial Hospital and Johns Hopkins Medicine to an inter...

Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

Murtha Cancer Center
Defense Health Programs with the U.S. Army Medical Research and Materiel Command

The registry is designed to update a suite of clinical decision-support tools designed for use when treating patients with metastatic bone disease. The models estimate the likelihood of survival at 1, 3, 6, 12, 18, and 24 months post surgery, which in turn, may be used for surgical decision-making.

Age

22 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult patients, age 22 or older
•Biopsy-proven or clinically-obvious metastatic bone disease
•Symptomatic bone lesion requiring intervention o Including, not limited to, radiotherapy, cryotherapy, radiofrequency ablation, operative fixation, prosthetic replacement, amputation, or any combination of the above.

Related studies

RECRUITINGPhase 1

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

NCT07197645 · Bone Pain, Metastatic Bone Tumor, and more

Hemiarthroplasty for Elderly With Proximal Humeral Mets

NCT07471022 · Bone Metastases of a Malignant Tumor, Metastatic Bone Tumor

ERAS Anesthetic Care for Metastatic Spine Cancer Resection

NCT05427825 · Metastatic Bone Tumor

Length of the Femoral Stem in Arthroplasty Done for Patients With Proximal Femoral Metastatic Lesion

NCT04660591 · Metastatic Bone Tumor, Pathological Fracture, and more

TERMINATEDPhase 2

Gemcitabine Plus Ascorbate for Sarcoma in Adults

NCT03468075 · Sarcoma, Soft Tissue Sarcoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 29, 2024Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment50

Start dateAug 2018

Last updatedOct 29, 2024

Condition

Metastatic Bone Tumor

Locations shown

Johns Hopkins

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 29, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions